ELEVANCE HEALTH DL-,01/ US0367521038 /
| 2024-11-07 8:04:48 AM | Chg. -1.0000 | Volume | Bid8:38:45 AM | Ask8:38:45 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 398.3000EUR | -0.25% | 0 Turnover: 0.0000 |
397.8000Bid Size: 15 | 399.9000Ask Size: 15 | 92.66 bill.EUR | - | - |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 3,133 | 3,483 | 3,919 | 4,316 | 4,359 | ||||||
| Intangible Assets | 8,674 | 9,405 | 10,615 | 10,315 | 10,273 | ||||||
| Long-Term Investments | 4,733 | 4,847 | 5,857 | 6,437 | 6,983 | ||||||
| Fixed Assets | 38,420 | 40,864 | 46,338 | 47,155 | 48,899 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 10,553 | 10,958 | 13,440 | 16,044 | 17,865 | ||||||
| Cash and Cash Equivalents | 4,937 | 5,741 | 4,880 | 7,387 | 6,526 | ||||||
| Current Assets | 39,033 | 45,751 | 51,122 | 55,617 | 60,029 | ||||||
| Total Assets | 77,453 | 86,615 | 97,460 | 102,755 | 108,928 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 13,040 | 16,852 | 18,488 | 21,203 | 23,021 | ||||||
| Long-term debt | 17,787 | 19,335 | 21,157 | 22,349 | 23,246 | ||||||
| Liabilities to Banks | 700 | 0.0000 | 275 | - | - | ||||||
| Provisions | 2,901 | 2,019 | 2,805 | - | - | ||||||
| Liabilities | 45,725 | 53,416 | 61,332 | 66,425 | 69,523 | ||||||
| Share Capital | 3 | 3 | 2 | 2 | 2 | ||||||
| Total Equity | 31,728 | 33,199 | 36,128 | 36,330 | 39,405 | ||||||
| Minority Interests | - | - | 68 | 87 | 99 | ||||||
| Total liabilities equity | 77,453 | 86,615 | 97,460 | 102,755 | 108,928 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 104,213 | 121,867 | 138,639 | 156,595 | 171,340 | ||||||
| Depreciation (total) | 338 | 361 | 441 | 767 | 885 | ||||||
| Operating Result | 5,999 | 6,360 | 7,489 | 8,283 | 8,499 | ||||||
| Interest Income | -746 | -784 | -798 | -851 | -1,030 | ||||||
| Income Before Taxes | 5,985 | 6,238 | 7,925 | 7,769 | 7,715 | ||||||
| Income Taxes | 1,178 | 1,666 | 1,830 | 1,750 | 1,724 | ||||||
| Minority Interests Profit | - | - | 9 | 6 | -4 | ||||||
| Net Income | 4,807 | 4,572 | 6,104 | 6,025 | 5,987 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 6,061 | 10,688 | 8,364 | 8,399 | 8,061 | ||||||
| Cash Flow from Investing Activities | -2,792 | -7,324 | -9,638 | -4,560 | -5,572 | ||||||
| Cash Flow from Financing | -2,266 | -2,567 | 423 | -1,318 | -3,349 | ||||||
| Decrease / Increase in Cash | 1,003 | 804 | -861 | 2,507 | -861 | ||||||
| Employees | 70,600 | 83,400 | 98,200 | - | - | ||||||
